Next Generation Summit

While tissue biopsies of cancer have been the gold standard for cancer patients, there are a variety of limitations that make the use of liquid biopsies attractive—and in many cases—preferable. Tissue biopsies are highly invasive, which limits their use for serial monitoring if they are available at...

While tissue biopsies of cancer have been the gold standard for cancer patients, there are a variety of limitations that make the use of liquid biopsies attractive—and in many cases—preferable. Tissue biopsies are highly invasive, which limits their use for serial monitoring if they are available at all. There may be some discordance between the two approaches, but there is growing recognition that liquid biopsies may provide earlier and more representative information. Liquid biopsies still face real challenges in terms of sensitivity, as well as challenges in clinical acceptance. Examination of successes in demonstrating the value of liquid biopsies for monitoring cancer patients for treatment selection, treatment response, disease prognosis, and disease recurrence will be highlighted. Examples targeting different biomarker classes, or combinations, will also be presented, and challenges for increased clinical use will be discussed.

• 35 strretKile streetBesttwon 
• 1

event link Visit Website Linkedin